Search results
Results from the WOW.Com Content Network
[3] Fenway Health: United States: 100–200 pg/mL <55 ng/dL [4] Callen-Lorde: United States "Some guidelines recommend checking estradiol and testosterone levels at baseline and throughout the monitoring of estrogen therapy. We have not found a clinical use for routine hormone levels that justifies the expense.
Thinning/slowed growth of facial/body hair: 4–12 months >3 years [c] Reversible Cessation/reversal of male-pattern scalp hair loss: 1–3 months: 1–2 years [d] Reversible Softening of skin/decreased oiliness and acne: 3–6 months: Unknown: Reversible Redistribution of body fat in a feminine pattern: 3–6 months: 2–5 years: Reversible ...
5–20 mg every 2 wks Estradiol cypionate: Depo-Estradiol: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol dipropionate: Agofollin: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol benzoate: Progynon-B: Estrogen: IM, SC: 0.5–1.5 mg every 2–3 days Estriol: Ovestin [c] Estrogen: Oral: 4–6 mg/day ...
Transgender men and those begin masculinizing hormone therapy see body fat redistributed within 3-6 months. Within 5 years, testosterone may cause gynoid fat to be significantly reduced. [18] [19] Inversely, transgender women, or those who begin feminizing hormone therapy, experience the formation of gynoid fat along with natural breast ...
Body roundness index (BRI) is a calculated geometric index used to quantify an aspect of a person's individual body shape. Based on the principle of body eccentricity, it provides a rapid visual and anthropometric tool for health evaluation. [1] Introduced in 2013, the BRI calculation can be used to estimate total and visceral body fat.
The BAI is calculated as: [2] Hip circumference (Pearson correlation coefficient, R = 0.602) and height (R = −0.524) are strongly correlated with percentage of body fat.. Comparing BAI with "gold standard" dual-energy X-ray absorptiometry (DXA) results, the correlation between DXA-derived percentage of adiposity and the BAI in a target population was R = 0.85, with a concordance of C_b = 0
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
This is an accepted version of this page This is the latest accepted revision, reviewed on 21 January 2025. Relative weight based on mass and height Medical diagnostic method Body mass index (BMI) Chart showing body mass index (BMI) for a range of heights and weights in both metric and imperial. Colours indicate BMI categories defined by the World Health Organization ; underweight, normal ...